DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, will hold a conference call on Monday, November 14, 2022 at 4:30 p.m. Eastern Time, to discuss its financial results for the third quarter ended September 30, 2022.
The live webcast of the conference call and related presentation slides can be accessed at ir.assureneuromonitoring.com/news-events/ir-calendar. An audio only option is available by following the connection instructions below. Investors opting for audio only will need to upload the associated slides to ir.assureneuromonitoring.com/company-information/presentations.
The Company will release its financial results in a press release prior to the conference call.
When: Monday, November 14, 2022
Time: 4:30 p.m. Eastern Time (2:30 p.m. Mountain Time)
Toll free: 1-800-274-8461
International dial-in number: 1-203-518-9814
Conference ID: ASSURE
Please call the conference phone number 5-10 minutes before the start time. An operator will register your name and organization.
The conference call will be broadcast live and available for replay here.
A replay of the conference call will be available after 7:30 p.m. Eastern Time the same day until November 28, 2022.
Toll-free replay number: 1-877-481-4010
International replay number: 1-919-882-2331
Replay ID: 47135
About Assure Holdings
Assure Holdings Corp. is a leading provider of outsourced intraoperative neuromonitoring and remote neurology services. The company provides a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that put the nervous system at risk, including neurosurgery, spine, cardiovascular, orthopedic and surgeries ears, nose and throat. Assure employs highly trained technologists who provide a direct point of contact in the operating room. Physicians employed by Assure affiliates simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure by communicating in real time with the surgeon and technologist. Accredited by the Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.
This press release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to, comments regarding: expectations regarding the growth and development of the Company and the quality and future service results. Forward-looking statements can generally be identified by the use of the words “anticipates”, “expects”, “intends”, “plans”, “should”, “could”, “might”, “could”. ‘, ‘will’, ‘believes’, ‘estimates’, ‘potential’, ‘target’ or ‘continues’ and variations or similar expressions. These statements are based on management’s current expectations and beliefs and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the operations and activities of the Company, its remote neurology activities and the economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our Annual Report on Form 10-K filed March 14, 2022 and available on the company’s EDGAR profile at the address www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend and assumes no obligation to update forward-looking statements to reflect, in particular, new information or future events.
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
Copyright 2022 GlobeNewswire, Inc.